7/23/2024  3:51:20 PM Chg. +0.07 Volume Bid- Ask3:52:36 PM Market Capitalization Dividend Y. P/E Ratio
16.69USD +0.42% 344
Turnover: 5,725.62
-Bid Size: - 16.71Ask Size: 100 3.6 bill.USD - -

Business description

Neogen Corporation (Nasdaq: NEOG) develops and markets products dedicated to food and animal safety. Neogen’s Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.
 

Management board & Supervisory board

CEO
John Adent
Management board
David Naemura, Amy M. Rocklin, Dr. Jason W. Lilly, Dr. Robert S. Donofrio, Jerome Hagedorn, Julie L. Mann, Byoung-Ik Sohn, Matt Mittino
Supervisory board
James C. Borel, Aashima Gupta, Catherine E. Woteki, James P. Tobin, Jeffrey Capello, Ralph A. Rodriguez, Ronald Green, William T. Boehm
 

Company data

Name: Neogen Corp.
Address: 620 Lesher Place,Lansing, Michigan 48912, USA
Phone: +1-517-372-9200
Fax: +1-517-372-2006
E-mail: corporate@neogen.com
Internet: www.neogen.com
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 5/31
Free Float: 60.89%
IPO date: -

Investor relations

Name: Steven J. Quinlan
IR phone: +1-517-372-2280
IR Fax: -
IR e-mail: ir@neogen.com

Company calendar

CW 31 | 7/30/2024 Report 4th Quarter
 

Main Shareholders

Freefloat
 
60.89%
Brown Capital Management, LLC
 
12.10%
Black Rock Institutional Trust Company, N.A.
 
11.40%
The Vanguard Group, Inc.
 
9.50%
Wasatch Advisors, Inc.
 
6.11%